Retapamulin
Back to searchMolecule Structure
Scientific Name
Retapamulin
Description of the Drug
Retapamulin is a topical antibiotic agent used for the treatment of impetigo caused by methicillin-susceptible Staphylococcus aureus or Streptococcus pyogenes.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01256
http://www.drugbank.ca/drugs/DB01256
Brand Name(s)
Aitabax, Altabax, Altargo
Company Owner(s)
Almirall Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
70S ribosome | PROTEIN NUCLEIC-ACID COMPLEX | INHIBITOR | CHEMBL2364096 |
70S ribosome | PROTEIN NUCLEIC-ACID COMPLEX | INHIBITOR | CHEMBL2364103 |
Clinical Trial(s)
Unichem Links
DrugBank | DB01256 | |
PubChem: Thomson Pharma | 16578667 | |
Nikkaji | J2.330.595J | |
PDBe | G34 | |
DrugCentral | 2371 | |
rxnorm | RETAPAMULIN | ALTABAX |
PubChem: Drugs of the Future | 12015312 | |
ZINC | ZINC000100013500 |